Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of flecainide controlled release (CR) in
the prevention of recurrent AF during 9 months of active treatment compared to placebo in
patients with only one documented AF episode.